Development of the RXR agonist IRX4204 to treat multiple sclerosis and other immune related diseases
Ended Project Grant Awarded Last action
- Award ID
- R44AI112512
- Recipient
-
IO Therapeutics, Inc. UEI TDXKKJF3U5E4
- Awarding agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Obligated
- $1,854,395
Award facts
- Assistance listing
- 93.855 Allergy and Infectious Diseases Research
- Completion date
- Place of performance
- Santa Ana, CA 92705, USA
Award details come from USAspending.gov.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Amendment | $0 | |
| Amendment | $1,000,000 | |
| Original award | $854,395 |
Quick answers
Who received award R44AI112512?
R44AI112512 was awarded to IO Therapeutics, Inc. by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on June 11, 2014.
How much is award R44AI112512 worth?
$1,854,395 has been obligated on R44AI112512.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award